Hello

Your subscription is almost coming to an end. Don’t miss out on the great content on Nation.Africa

Ready to continue your informative journey with us?

Hello

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features.

Reclaim your full access. Click below to renew.

Winners of flawed Kemsa tenders to return money

Covid-19 vaccine

A medical attendant prepares to vaccinate health workers with Chinese-made Sinopharm Covid-19 vaccine.

Photo credit: Arif Ali | AFP

Companies and individuals that were beneficiaries of flawed Covid-19 procurement at Kenya Medical Supplies Authority (Kemsa) will be made to return the excess cash received, Solicitor-General Kennedy Ogeto has said.

Appearing before the National Assembly Public Investment Committee yesterday, Mr Ogeto said entities that supplied items at inflated prices and have not been paid will only get their money based on current rates.